News
AGMB
7.02
+0.36%
0.03
Weekly Report: what happened at AGMB last week (1102-1106)?
Weekly Report · 2d ago
Weekly Report: what happened at AGMB last week (1026-1030)?
Weekly Report · 11/02 10:31
Agomab Therapeutics NV trading resumes
TipRanks · 10/30 13:50
Agomab Therapeutics NV trading halted, volatility trading pause
TipRanks · 10/30 13:47
Analysts Are Bullish on Top Healthcare Stocks: Pharvaris (PHVS), AgomAb Therapeutics NV ADR (AGMB)
TipRanks · 10/26 13:20
Weekly Report: what happened at AGMB last week (1019-1023)?
Weekly Report · 10/26 10:30
Analysts Offer Insights on Healthcare Companies: AgomAb Therapeutics NV ADR (AGMB) and Evaxion Biotech (EVAX)
TipRanks · 10/20 20:30
Analysts’ Top Healthcare Picks: BioNTech SE (BNTX), AgomAb Therapeutics NV ADR (AGMB)
TipRanks · 10/19 12:50
Weekly Report: what happened at AGMB last week (1012-1016)?
Weekly Report · 10/19 10:30
AgomAb Therapeutics NV ADR (AGMB) Gets a Buy from Piper Sandler
TipRanks · 10/14 11:25
Analysts Are Bullish on Top Healthcare Stocks: Alvotech (ALVO), Relay Therapeutics (RLAY)
TipRanks · 10/12 12:30
Weekly Report: what happened at AGMB last week (1005-1009)?
Weekly Report · 10/12 10:36
Insider Move: AgomAb Therapeutics Director Makes a Bold New Bet
TipRanks · 10/10 02:00
Analysts Offer Insights on Healthcare Companies: AgomAb Therapeutics NV ADR (AGMB) and Pharvaris (PHVS)
TipRanks · 10/05 12:40
AgomAb Therapeutics NV ADR (AGMB) Receives a Buy from Piper Sandler
TipRanks · 10/05 11:55
Weekly Report: what happened at AGMB last week (0928-1002)?
Weekly Report · 10/05 10:36
Leerink Partners Reaffirms Their Buy Rating on AgomAb Therapeutics NV ADR (AGMB)
TipRanks · 10/02 12:15
Analysts Offer Insights on Healthcare Companies: AgomAb Therapeutics NV ADR (AGMB) and Jade Biosciences (JBIO)
TipRanks · 10/01 12:50
Agomab Posts Positive 60-Week Data for Ontunisertib in Fibrostenosing Crohn’s Disease, Readies Phase 2b NOV-ERA Trial
TipRanks · 10/01 10:57
Agomab’s ontunisertib shows positive results in Crohn’s Disease study
TipRanks · 10/01 10:35
More
Webull provides a variety of real-time AGMB stock news. You can receive the latest news about AgomAb Therapeutics NV through multiple platforms. This information may help you make smarter investment decisions.
About AGMB
Agomab Therapeutics NV is a Belgium-based company. The Company is engaged in research and development services creating therapies for fibrotic and inflammatory diseases. Its activities include discovery research to identify drug candidates that act on pathways involved in fibrosis and tissue repair, such as organ restricted small molecules and growth factor targeting antibodies. The Company also carries out preclinical development, including work on programs, to evaluate drug behavior and readiness before entering human studies. In addition, It conducts clinical development services by sponsoring and managing trials for its pipeline, assessing safety, tolerability, pharmacokinetics, and pharmacodynamics.